Showing results (71-80 of 439) with videos related to
Sort By:
Pageof 44
Best Practice & Research. Clinical Haematology|November 1, 2003
Diagnostic value of detecting fusion proteins derived from chromosome translocations in acute leukaemiaFrancesco Lo-Coco, Massimo Breccia, Nélida Noguera, et al.Annals of Hematology|October 12, 2014
Application of systematic coronary risk evaluation chart to identify chronic myeloid leukemia patients at risk of cardiovascular diseases during nilotinib treatmentMassimo Breccia, Matteo Molica, Irene Zacheo, et al.Expert Review of Hematology|July 18, 2017
Is now the time for molecular driven therapy for diffuse large B-cell lymphoma?Alice Di Rocco, Federico De Angelis, Michela Ansuinelli, et al.Therapeutic Advances in Hematology|March 12, 2019
Insights into the optimal use of ponatinib in patients with chronic phase chronic myeloid leukaemiaMatteo Molica, Emilia Scalzulli, Gioia Colafigli, et al.Bone Marrow Transplantation|September 20, 2019
The role of allogeneic stem-cell transplant in myelofibrosis in the era of JAK inhibitors: a case-based reviewMario Tiribelli, Francesca Palandri, Emanuela Sant'Antonio, et al.Leukemia Research|July 22, 2016
Early molecular response in chronic myeloid leukemia and halving time: Latest evidencesMassimo Breccia, Matteo Molica, Gioia Colafigli, et al.American Journal of Hematology|August 21, 2019
Maintenance therapy in AML: The past, the present and the futureMatteo Molica, Massimo Breccia, Roberto Foa, et al.Current Opinion in Oncology|August 26, 2022
Novel therapeutic agents for myelofibrosis after failure or suboptimal response to JAK2 inhbitorsMassimo Breccia, Giovanni Manfredi Assanto, Alessandro Laganà, et al.Cancers|June 26, 2026
Four Decades of Molecular Innovation in Chronic Myeloid Leukemia: From Antisense Targeting to Treatment-Free RemissionMaria Stefania De Propris, Alessandro Laganà, Massimo Breccia, et al.Current Hematologic Malignancy Reports|October 20, 2022
CML Resistant to 2nd-Generation TKIs: Mechanisms, Next Steps, and New DirectionsEmilia Scalzulli, Ida Carmosino, Maria Laura Bisegna, et al.Pageof 44